Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

BioAge Labs (BIOA) Interest & Investment Income (2023 - 2026)

BioAge Labs' Interest & Investment Income history spans 2 years, with the latest figure at $2.8 million for Q4 2025.

  • On a quarterly basis, Interest & Investment Income fell 31.82% to $2.8 million in Q4 2025 year-over-year; TTM through Dec 2025 was $13.1 million, a 35.9% increase, with the full-year FY2025 number at $13.1 million, up 35.9% from a year prior.
  • Interest & Investment Income hit $2.8 million in Q4 2025 for BioAge Labs, down from $3.2 million in the prior quarter.
  • Over the last five years, Interest & Investment Income for BIOA hit a ceiling of $4.1 million in Q4 2024 and a floor of $1.3 million in Q1 2024.